GNH USA

Europe — EMA

Levofloxacin Krka

GNH USA supplies Levofloxacin Krka (Levofloxacin), a fluoroquinolone antibiotic for respiratory, urinary and skin infections.

Levofloxacin

Request sourcing

1
Pack/s

What is Levofloxacin?

Levofloxacin, the active ingredient in Levofloxacin Krka, is a fluoroquinolone antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections, including community‑acquired respiratory tract infections, urinary tract infections, skin and soft‑tissue infections, acute bacterial sinusitis, and acute bacterial prostatitis in adult patients.

GNH USA supplies Levofloxacin Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

What is Levofloxacin used for?

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, and skin systems.

Community‑acquired respiratory tract infections: achieves bacterial eradication and clinical cure. Urinary tract infections: eliminates causative pathogens and resolves symptoms. Skin and soft‑tissue infections: provides rapid bacterial clearance and promotes healing. Acute bacterial sinusitis: clears infection and restores sinus ventilation. Acute bacterial prostatitis: eradicates prostate infection and improves urinary function.

What are the side effects of Levofloxacin?

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Tendon rupture or tendonitis - QT interval prolongation - Clostridioides difficile‑associated colitis - Severe allergic reactions (anaphylaxis) - Peripheral neuropathy - Hepatic dysfunction

What precautions apply to Levofloxacin?

When prescribing Levofloxacin, clinicians should consider several safety precautions to minimize risk.

Assess renal function: adjust dose in patients with impaired clearance. Avoid in known tendon disorders: increased risk of tendon rupture. Monitor cardiac status: risk of QT prolongation, especially with other QT‑prolonging agents. Use cautiously in the elderly: higher incidence of adverse events. Avoid concomitant NSAIDs: combined use may potentiate tendon toxicity. Store at room temperature: keep in original packaging, protect from moisture.

What does Levofloxacin interact with?

Levofloxacin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Theophylline: elevated plasma levels can cause toxicity. - NSAIDs: combined use raises risk of tendon injury.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced effectiveness, consider backup method. - Diabetic agents (insulin, sulfonylureas): enhanced hypoglycemic effect. - Corticosteroids: additive risk of tendon rupture.

Frequently asked questions

What infections is Levofloxacin Krka used to treat?+
Levofloxacin Krka is employed to treat a range of bacterial infections, including community‑acquired respiratory tract infections, urinary tract infections, skin and soft‑tissue infections, acute bacterial sinusitis, and acute bacterial prostatitis. It is prescribed for adult patients when a fluoroquinolone is appropriate based on susceptibility testing and clinical judgment.
How does levofloxacin work against bacteria?+
Levofloxacin exerts its antibacterial effect by inhibiting two essential enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are required for DNA supercoiling and replication. By binding to them, levofloxacin prevents bacterial DNA synthesis and transcription, leading to rapid bacterial cell death.
What is the usual dose of Levofloxacin Krka?+
The specific dose of Levofloxacin Krka is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and local resistance patterns. Healthcare professionals should follow current clinical guidelines and the product label when selecting the appropriate regimen.
Is Levofloxacin Krka safe to use during pregnancy or breastfeeding?+
Safety data for levofloxacin in pregnancy are limited, and the drug is generally avoided unless the potential benefit outweighs the risk to the fetus. It is also excreted in breast milk, so breastfeeding mothers should discuss alternatives with their healthcare provider. Consultation with a specialist is recommended.
How do I order Levofloxacin Krka from GNH USA?+
To request Levofloxacin Krka, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Levofloxacin compare with other fluoroquinolones such as ciprofloxacin?+
Levofloxacin offers a broader spectrum of activity against Gram‑positive organisms compared with ciprofloxacin, while both share similar activity against many Gram‑negative pathogens. Levofloxacin is often dosed once daily, which can improve adherence, whereas ciprofloxacin typically requires twice‑daily dosing. Both share class‑related safety considerations, so selection depends on infection site, susceptibility, and patient factors.
What are the recommended storage conditions for Levofloxacin Krka?+
Levofloxacin Krka should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Do not store in areas of high humidity or near heat sources. Keep the product out of reach of children.
How is Levofloxacin Krka administered?+
Levofloxacin Krka is administered orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid taking it simultaneously with antacids or mineral supplements that contain calcium, magnesium, aluminum, or iron, as these can impair absorption.
What are the most serious risks associated with Levofloxacin Krka?+
The most serious risks include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation leading to cardiac arrhythmias; Clostridioides difficile‑associated colitis; severe allergic reactions such as anaphylaxis; peripheral neuropathy; and hepatic dysfunction. Patients should be educated to report any sudden joint pain, palpitations, severe diarrhea, or rash promptly.
Who should not use Levofloxacin Krka?+
Levofloxacin Krka should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, patients with a history of tendon disorders related to fluoroquinolone use, and those taking concomitant medications that significantly increase the risk of tendon injury. Caution is also advised for patients with uncontrolled epilepsy, myasthenia gravis, or severe renal impairment, and it is generally not recommended for pregnant or nursing women unless absolutely necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levofloxacin
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products